Detalles de la búsqueda
1.
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.
Lancet Oncol
; 16(8): 897-907, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26156651
2.
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial.
EClinicalMedicine
; 37: 100940, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34195574
3.
Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea.
Asia Pac J Clin Oncol
; 11(4): 282-7, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25856172
Resultados
1 -
3
de 3
1
Próxima >
>>